214 related articles for article (PubMed ID: 32989144)
1. Driver mutations of the adenoma-carcinoma sequence govern the intestinal epithelial global translational capacity.
Smit WL; Spaan CN; Johannes de Boer R; Ramesh P; Martins Garcia T; Meijer BJ; Vermeulen JLM; Lezzerini M; MacInnes AW; Koster J; Medema JP; van den Brink GR; Muncan V; Heijmans J
Proc Natl Acad Sci U S A; 2020 Oct; 117(41):25560-25570. PubMed ID: 32989144
[TBL] [Abstract][Full Text] [Related]
2. The concerted action of oncogenic driver mutations directs global translation in intestinal epithelial cells.
Smit W; Heijmans J
Mol Cell Oncol; 2021; 8(4):1879614. PubMed ID: 34616863
[TBL] [Abstract][Full Text] [Related]
3. SLC25A22 Promotes Proliferation and Survival of Colorectal Cancer Cells With KRAS Mutations and Xenograft Tumor Progression in Mice via Intracellular Synthesis of Aspartate.
Wong CC; Qian Y; Li X; Xu J; Kang W; Tong JH; To KF; Jin Y; Li W; Chen H; Go MY; Wu JL; Cheng KW; Ng SS; Sung JJ; Cai Z; Yu J
Gastroenterology; 2016 Nov; 151(5):945-960.e6. PubMed ID: 27451147
[TBL] [Abstract][Full Text] [Related]
4. MET Signaling Mediates Intestinal Crypt-Villus Development, Regeneration, and Adenoma Formation and Is Promoted by Stem Cell CD44 Isoforms.
Joosten SPJ; Zeilstra J; van Andel H; Mijnals RC; Zaunbrecher J; Duivenvoorden AAM; van de Wetering M; Clevers H; Spaargaren M; Pals ST
Gastroenterology; 2017 Oct; 153(4):1040-1053.e4. PubMed ID: 28716720
[TBL] [Abstract][Full Text] [Related]
5. mTORC1 signalling and eIF4E/4E-BP1 translation initiation factor stoichiometry influence recombinant protein productivity from GS-CHOK1 cells.
Jossé L; Xie J; Proud CG; Smales CM
Biochem J; 2016 Dec; 473(24):4651-4664. PubMed ID: 27760840
[TBL] [Abstract][Full Text] [Related]
6. Modeling colorectal cancer using CRISPR-Cas9-mediated engineering of human intestinal organoids.
Matano M; Date S; Shimokawa M; Takano A; Fujii M; Ohta Y; Watanabe T; Kanai T; Sato T
Nat Med; 2015 Mar; 21(3):256-62. PubMed ID: 25706875
[TBL] [Abstract][Full Text] [Related]
7. Translational repression of Ccl5 and Cxcl10 by 4E-BP1 and 4E-BP2 restrains the ability of mouse macrophages to induce migration of activated T cells.
William M; Leroux LP; Chaparro V; Graber TE; Alain T; Jaramillo M
Eur J Immunol; 2019 Aug; 49(8):1200-1212. PubMed ID: 31032899
[TBL] [Abstract][Full Text] [Related]
8. PTEN loss and KRAS activation leads to the formation of serrated adenomas and metastatic carcinoma in the mouse intestine.
Davies EJ; Marsh Durban V; Meniel V; Williams GT; Clarke AR
J Pathol; 2014 May; 233(1):27-38. PubMed ID: 24293351
[TBL] [Abstract][Full Text] [Related]
9. Sequential cancer mutations in cultured human intestinal stem cells.
Drost J; van Jaarsveld RH; Ponsioen B; Zimberlin C; van Boxtel R; Buijs A; Sachs N; Overmeer RM; Offerhaus GJ; Begthel H; Korving J; van de Wetering M; Schwank G; Logtenberg M; Cuppen E; Snippert HJ; Medema JP; Kops GJ; Clevers H
Nature; 2015 May; 521(7550):43-7. PubMed ID: 25924068
[TBL] [Abstract][Full Text] [Related]
10. Combined Mutation of
Sakai E; Nakayama M; Oshima H; Kouyama Y; Niida A; Fujii S; Ochiai A; Nakayama KI; Mimori K; Suzuki Y; Hong CP; Ock CY; Kim SJ; Oshima M
Cancer Res; 2018 Mar; 78(5):1334-1346. PubMed ID: 29282223
[TBL] [Abstract][Full Text] [Related]
11. Translation initiation factor eIF2Bε promotes Wnt-mediated clonogenicity and global translation in intestinal epithelial cells.
Smit WL; de Boer RJ; Meijer BJ; Spaan CN; van Roest M; Koelink PJ; Koster J; Dekker E; Abbink TEM; van der Knaap MS; van den Brink GR; Muncan V; Heijmans J
Stem Cell Res; 2021 Aug; 55():102499. PubMed ID: 34399164
[TBL] [Abstract][Full Text] [Related]
12. Different mutation profiles associated to P53 accumulation in colorectal cancer.
López I; P Oliveira L; Tucci P; Alvarez-Valín F; A Coudry R; Marín M
Gene; 2012 May; 499(1):81-7. PubMed ID: 22373952
[TBL] [Abstract][Full Text] [Related]
13. Gene promoter and exon DNA methylation changes in colon cancer development - mRNA expression and tumor mutation alterations.
Molnár B; Galamb O; Péterfia B; Wichmann B; Csabai I; Bodor A; Kalmár A; Szigeti KA; Barták BK; Nagy ZB; Valcz G; Patai ÁV; Igaz P; Tulassay Z
BMC Cancer; 2018 Jun; 18(1):695. PubMed ID: 29945573
[TBL] [Abstract][Full Text] [Related]
14. mTORC1 Inactivation Promotes Colitis-Induced Colorectal Cancer but Protects from APC Loss-Dependent Tumorigenesis.
Brandt M; Grazioso TP; Fawal MA; Tummala KS; Torres-Ruiz R; Rodriguez-Perales S; Perna C; Djouder N
Cell Metab; 2018 Jan; 27(1):118-135.e8. PubMed ID: 29275959
[TBL] [Abstract][Full Text] [Related]
15. Altered miR-21, miRNA-148a Expression in Relation to KRAS Mutation Status as Indicator of Adenoma-Carcinoma Transitional Pattern in Colorectal Adenoma and Carcinoma Lesions.
Igder S; Mohammadiasl J; Mokarram P
Biochem Genet; 2019 Dec; 57(6):767-780. PubMed ID: 30997628
[TBL] [Abstract][Full Text] [Related]
16. Reappraisal to the study of 4E-BP1 as an mTOR substrate - A normative critique.
Batool A; Aashaq S; Andrabi KI
Eur J Cell Biol; 2017 Jun; 96(4):325-336. PubMed ID: 28427795
[TBL] [Abstract][Full Text] [Related]
17. The mTORC1/4E-BP/eIF4E Axis Promotes Antibody Class Switching in B Lymphocytes.
Chiu H; Jackson LV; Oh KI; Mai A; Ronai ZA; Ruggero D; Fruman DA
J Immunol; 2019 Jan; 202(2):579-590. PubMed ID: 30530594
[TBL] [Abstract][Full Text] [Related]
18. Eukaryotic initiation factor 4E is a novel effector of mTORC1 signaling pathway in cross talk with Mnk1.
Batool A; Majeed ST; Aashaq S; Majeed R; Bhat NN; Andrabi KI
Mol Cell Biochem; 2020 Feb; 465(1-2):13-26. PubMed ID: 31782083
[TBL] [Abstract][Full Text] [Related]
19. Transcriptional and metabolic rewiring of colorectal cancer cells expressing the oncogenic KRAS
Charitou T; Srihari S; Lynn MA; Jarboui MA; Fasterius E; Moldovan M; Shirasawa S; Tsunoda T; Ueffing M; Xie J; Xin J; Wang X; Proud CG; Boldt K; Al-Khalili Szigyarto C; Kolch W; Lynn DJ
Br J Cancer; 2019 Jul; 121(1):37-50. PubMed ID: 31133691
[TBL] [Abstract][Full Text] [Related]
20. Elevated Coexpression of KITENIN and the ErbB4 CYT-2 Isoform Promotes the Transition from Colon Adenoma to Carcinoma Following APC loss.
Bae JA; Kho DH; Sun EG; Ko YS; Yoon S; Lee KH; Ahn KY; Lee JH; Joo YE; Chung IJ; Lee SH; Kim H; Kim KK
Clin Cancer Res; 2016 Mar; 22(5):1284-94. PubMed ID: 26527747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
